Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry
M. Pinto Mendes (Vila Nova de Gaia, Portugal), S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), E. Polverino (Barceloma, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Sint-Niklaas, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pinto Mendes (Vila Nova de Gaia, Portugal), S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), E. Polverino (Barceloma, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Sint-Niklaas, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom). Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry. 356
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015
Validity of general practitioner-made diagnosis of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 688s Year: 2004
Validity of the diagnosis of pneumonia in hospitalised patients with COPD Source: ERJ Open Res, 5 (2) 00031-2019; 10.1183/23120541.00031-2019 Year: 2019
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Evaluation of multiple admissions of COPD patients: European COPD audit Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012
Clinical diagnosis of COPD Source: Virtual Congress 2020 – Russian speaking programme 2020: Part II Year: 2020
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Patterns of airway disease and the clinical diagnosis of asthma in the Busselton population Source: Eur Respir J 2011; 38: 1053-1059 Year: 2011
Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Defining asthma COPD overlap syndrome (ACOS): A population based study Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016
Diagnostic characteristics of questionnaires for identification of obstructive lung disease Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Alpha1-antytripsin deficiency in portuguese COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Clinical cases: COPD and bronchiectasis Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017
Accuracy of questionnaire with peak flow for diagnosis of airway obstruction and differentiating between asthma and COPD Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015
Comorbidities and burden of COPD: A population based case-control study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013
Diagnosis confirmation and staging in patients hospitalized with diagnosis of COPD in a general hospital with adequate resources Source: Annual Congress 2013 –COPD treatment Year: 2013
Symptom questionnaire and laboratory findings in COPD patients diagnosed by spirometry in Korea Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006
Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome Source: Annual Congress 2013 –Asthma at the bedside Year: 2013